HEADER LIGASE/INHIBITOR 04-JAN-17 5UFI TITLE DCN1 BOUND TO DI-591 COMPND MOL_ID: 1; COMPND 2 MOLECULE: DCN1-LIKE PROTEIN 1; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: UNP RESIDUES 58-259; COMPND 5 SYNONYM: DCUN1 DOMAIN-CONTAINING PROTEIN 1,DEFECTIVE IN CULLIN COMPND 6 NEDDYLATION PROTEIN 1-LIKE PROTEIN 1,SQUAMOUS CELL CARCINOMA-RELATED COMPND 7 ONCOGENE; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: DCUN1D1, DCUN1L1, RP42, SCCRO; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS E3 LIGASE, COMPLEX, LIGASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.STUCKEY REVDAT 4 03-APR-24 5UFI 1 REMARK REVDAT 3 06-MAR-24 5UFI 1 REMARK REVDAT 2 08-NOV-17 5UFI 1 JRNL REVDAT 1 01-NOV-17 5UFI 0 JRNL AUTH H.ZHOU,J.LU,L.LIU,D.BERNARD,C.Y.YANG,E.FERNANDEZ-SALAS, JRNL AUTH 2 K.CHINNASWAMY,S.LAYTON,J.STUCKEY,Q.YU,W.ZHOU,Z.PAN,Y.SUN, JRNL AUTH 3 S.WANG JRNL TITL A POTENT SMALL-MOLECULE INHIBITOR OF THE DCN1-UBC12 JRNL TITL 2 INTERACTION THAT SELECTIVELY BLOCKS CULLIN 3 NEDDYLATION. JRNL REF NAT COMMUN V. 8 1150 2017 JRNL REFN ESSN 2041-1723 JRNL PMID 29074978 JRNL DOI 10.1038/S41467-017-01243-7 REMARK 2 REMARK 2 RESOLUTION. 2.58 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.58 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.24 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 35332 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.211 REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.980 REMARK 3 FREE R VALUE TEST SET COUNT : 1758 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.000 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 18 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.58 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.65 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.28 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2789 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2420 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2661 REMARK 3 BIN R VALUE (WORKING SET) : 0.2390 REMARK 3 BIN FREE R VALUE : 0.3120 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.59 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 128 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6212 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 164 REMARK 3 SOLVENT ATOMS : 40 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 58.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 43.79 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.38600 REMARK 3 B22 (A**2) : -0.05280 REMARK 3 B33 (A**2) : 1.43870 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.350 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.431 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.258 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.443 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.264 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.932 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.909 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 6565 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 8880 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 3092 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 202 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 971 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 6565 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 815 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 7479 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.01 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.77 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 3.13 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: {A|60 - 251} REMARK 3 ORIGIN FOR THE GROUP (A): 0.5122 8.5990 43.6818 REMARK 3 T TENSOR REMARK 3 T11: -0.0809 T22: -0.1241 REMARK 3 T33: -0.0839 T12: -0.0111 REMARK 3 T13: -0.0131 T23: 0.0757 REMARK 3 L TENSOR REMARK 3 L11: 1.6120 L22: 1.0609 REMARK 3 L33: 3.6302 L12: 0.4341 REMARK 3 L13: 1.2320 L23: 0.4998 REMARK 3 S TENSOR REMARK 3 S11: -0.1561 S12: 0.0029 S13: 0.2429 REMARK 3 S21: -0.0163 S22: 0.0469 S23: 0.0491 REMARK 3 S31: -0.1817 S32: 0.0090 S33: 0.1093 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: {B|60 - 251} REMARK 3 ORIGIN FOR THE GROUP (A): -0.2514 15.5768 -2.6923 REMARK 3 T TENSOR REMARK 3 T11: -0.0710 T22: -0.0833 REMARK 3 T33: -0.1285 T12: -0.0136 REMARK 3 T13: 0.0273 T23: -0.0444 REMARK 3 L TENSOR REMARK 3 L11: 1.1189 L22: 1.1993 REMARK 3 L33: 3.4638 L12: -0.2519 REMARK 3 L13: 1.0228 L23: -0.4540 REMARK 3 S TENSOR REMARK 3 S11: 0.0475 S12: 0.0085 S13: 0.0440 REMARK 3 S21: 0.0518 S22: -0.0456 S23: 0.0028 REMARK 3 S31: -0.1846 S32: 0.0192 S33: -0.0018 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: {C|60 - 251} REMARK 3 ORIGIN FOR THE GROUP (A): 0.1830 -13.6048 47.4370 REMARK 3 T TENSOR REMARK 3 T11: -0.1054 T22: -0.1521 REMARK 3 T33: -0.1131 T12: -0.0435 REMARK 3 T13: -0.0267 T23: 0.0355 REMARK 3 L TENSOR REMARK 3 L11: 3.7953 L22: 1.7696 REMARK 3 L33: 1.5222 L12: -0.3472 REMARK 3 L13: -0.2461 L23: 0.2309 REMARK 3 S TENSOR REMARK 3 S11: 0.0021 S12: 0.0026 S13: -0.1164 REMARK 3 S21: -0.0193 S22: 0.1103 S23: -0.2183 REMARK 3 S31: 0.1177 S32: 0.0632 S33: -0.1125 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: {D|60 - 251} REMARK 3 ORIGIN FOR THE GROUP (A): -0.1563 -6.7429 -6.2465 REMARK 3 T TENSOR REMARK 3 T11: -0.1275 T22: -0.1363 REMARK 3 T33: -0.1365 T12: 0.0025 REMARK 3 T13: 0.0330 T23: -0.0293 REMARK 3 L TENSOR REMARK 3 L11: 3.1030 L22: 1.9347 REMARK 3 L33: 1.8896 L12: -0.4041 REMARK 3 L13: -0.5673 L23: 0.3003 REMARK 3 S TENSOR REMARK 3 S11: -0.0514 S12: 0.0300 S13: -0.4287 REMARK 3 S21: 0.1786 S22: -0.0159 S23: 0.2335 REMARK 3 S31: 0.3130 S32: 0.0006 S33: 0.0673 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5UFI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-JAN-17. REMARK 100 THE DEPOSITION ID IS D_1000225779. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-JUL-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-F REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9787 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000, HKL REMARK 200 DATA SCALING SOFTWARE : HKL-2000, HKL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35513 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.580 REMARK 200 RESOLUTION RANGE LOW (A) : 45.240 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 5.300 REMARK 200 R MERGE (I) : 0.08400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.58 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.62 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 5.20 REMARK 200 R MERGE FOR SHELL (I) : 0.61600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: IN-HOUSE MODEL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.86 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.61 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 4000 AND 100 MM POTASSIUM REMARK 280 PHOSPHATE (MONOBASIC), VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 31.07100 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 86.76050 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 50.82350 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 86.76050 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 31.07100 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 50.82350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 35 REMARK 465 SER A 36 REMARK 465 TYR A 37 REMARK 465 TYR A 38 REMARK 465 HIS A 39 REMARK 465 HIS A 40 REMARK 465 HIS A 41 REMARK 465 HIS A 42 REMARK 465 HIS A 43 REMARK 465 HIS A 44 REMARK 465 LEU A 45 REMARK 465 GLU A 46 REMARK 465 SER A 47 REMARK 465 THR A 48 REMARK 465 SER A 49 REMARK 465 LEU A 50 REMARK 465 TYR A 51 REMARK 465 LYS A 52 REMARK 465 LYS A 53 REMARK 465 ALA A 54 REMARK 465 GLY A 55 REMARK 465 THR A 56 REMARK 465 MET A 57 REMARK 465 GLY A 58 REMARK 465 SER A 59 REMARK 465 ALA A 252 REMARK 465 GLY A 253 REMARK 465 THR A 254 REMARK 465 LYS A 255 REMARK 465 SER A 256 REMARK 465 THR A 257 REMARK 465 THR A 258 REMARK 465 VAL A 259 REMARK 465 MET B 35 REMARK 465 SER B 36 REMARK 465 TYR B 37 REMARK 465 TYR B 38 REMARK 465 HIS B 39 REMARK 465 HIS B 40 REMARK 465 HIS B 41 REMARK 465 HIS B 42 REMARK 465 HIS B 43 REMARK 465 HIS B 44 REMARK 465 LEU B 45 REMARK 465 GLU B 46 REMARK 465 SER B 47 REMARK 465 THR B 48 REMARK 465 SER B 49 REMARK 465 LEU B 50 REMARK 465 TYR B 51 REMARK 465 LYS B 52 REMARK 465 LYS B 53 REMARK 465 ALA B 54 REMARK 465 GLY B 55 REMARK 465 THR B 56 REMARK 465 MET B 57 REMARK 465 GLY B 58 REMARK 465 ALA B 252 REMARK 465 GLY B 253 REMARK 465 THR B 254 REMARK 465 LYS B 255 REMARK 465 SER B 256 REMARK 465 THR B 257 REMARK 465 THR B 258 REMARK 465 VAL B 259 REMARK 465 MET C 35 REMARK 465 SER C 36 REMARK 465 TYR C 37 REMARK 465 TYR C 38 REMARK 465 HIS C 39 REMARK 465 HIS C 40 REMARK 465 HIS C 41 REMARK 465 HIS C 42 REMARK 465 HIS C 43 REMARK 465 HIS C 44 REMARK 465 LEU C 45 REMARK 465 GLU C 46 REMARK 465 SER C 47 REMARK 465 THR C 48 REMARK 465 SER C 49 REMARK 465 LEU C 50 REMARK 465 TYR C 51 REMARK 465 LYS C 52 REMARK 465 LYS C 53 REMARK 465 ALA C 54 REMARK 465 GLY C 55 REMARK 465 THR C 56 REMARK 465 MET C 57 REMARK 465 GLY C 58 REMARK 465 SER C 59 REMARK 465 ALA C 252 REMARK 465 GLY C 253 REMARK 465 THR C 254 REMARK 465 LYS C 255 REMARK 465 SER C 256 REMARK 465 THR C 257 REMARK 465 THR C 258 REMARK 465 VAL C 259 REMARK 465 MET D 35 REMARK 465 SER D 36 REMARK 465 TYR D 37 REMARK 465 TYR D 38 REMARK 465 HIS D 39 REMARK 465 HIS D 40 REMARK 465 HIS D 41 REMARK 465 HIS D 42 REMARK 465 HIS D 43 REMARK 465 HIS D 44 REMARK 465 LEU D 45 REMARK 465 GLU D 46 REMARK 465 SER D 47 REMARK 465 THR D 48 REMARK 465 SER D 49 REMARK 465 LEU D 50 REMARK 465 TYR D 51 REMARK 465 LYS D 52 REMARK 465 LYS D 53 REMARK 465 ALA D 54 REMARK 465 GLY D 55 REMARK 465 THR D 56 REMARK 465 MET D 57 REMARK 465 GLY D 58 REMARK 465 SER D 59 REMARK 465 ALA D 252 REMARK 465 GLY D 253 REMARK 465 THR D 254 REMARK 465 LYS D 255 REMARK 465 SER D 256 REMARK 465 THR D 257 REMARK 465 THR D 258 REMARK 465 VAL D 259 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 63 CG CD CE NZ REMARK 470 LYS A 149 CE NZ REMARK 470 LYS A 171 CG CD CE NZ REMARK 470 ARG A 206 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 232 CG CD OE1 OE2 REMARK 470 GLU A 233 CG CD OE1 OE2 REMARK 470 LYS B 63 CG CD CE NZ REMARK 470 LYS B 171 CG CD CE NZ REMARK 470 LYS B 205 CG CD CE NZ REMARK 470 ASP B 211 CG OD1 OD2 REMARK 470 ASP B 231 CG OD1 OD2 REMARK 470 LYS C 63 CG CD CE NZ REMARK 470 GLN C 67 CG CD OE1 NE2 REMARK 470 GLU C 135 CG CD OE1 OE2 REMARK 470 LYS C 149 CG CD CE NZ REMARK 470 LYS C 171 CD CE NZ REMARK 470 LYS C 198 CG CD CE NZ REMARK 470 HIS C 203 CG ND1 CD2 CE1 NE2 REMARK 470 HIS C 204 CG ND1 CD2 CE1 NE2 REMARK 470 LYS C 205 CG CD CE NZ REMARK 470 ARG C 206 CG CD NE CZ NH1 NH2 REMARK 470 GLU C 232 CG CD OE1 OE2 REMARK 470 GLU C 233 CG CD OE1 OE2 REMARK 470 ARG D 62 CG CD NE CZ NH1 NH2 REMARK 470 LYS D 63 CG CD CE NZ REMARK 470 LYS D 64 CG CD CE NZ REMARK 470 GLU D 66 CG CD OE1 OE2 REMARK 470 LYS D 149 CG CD CE NZ REMARK 470 LYS D 171 CG CD CE NZ REMARK 470 LYS D 191 CG CD CE NZ REMARK 470 LYS D 198 CG CD CE NZ REMARK 470 HIS D 204 CG ND1 CD2 CE1 NE2 REMARK 470 LYS D 205 CG CD CE NZ REMARK 470 ARG D 206 CG CD NE CZ NH1 NH2 REMARK 470 GLU D 232 CG CD OE1 OE2 REMARK 470 GLU D 233 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 204 45.06 28.80 REMARK 500 GLU B 233 77.78 -104.56 REMARK 500 ARG C 189 19.42 -141.32 REMARK 500 HIS D 204 96.79 24.27 REMARK 500 REMARK 500 REMARK: NULL REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 8B1 C 301 REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: N-[(1S)-1-CYCLOHEXYL-2-{[3-(MORPHOLIN-4-YL) REMARK 630 PROPANOYL]AMINO}ETHYL]-N~2~-PROPANOYL-3-[6-(PROPAN-2-YL)-1,3- REMARK 630 BENZOTHIAZOL-2-YL]-L-ALANINAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 8B1 A 301 REMARK 630 8B1 B 301 REMARK 630 8B1 C 301 REMARK 630 8B1 D 301 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: 8AS 8AV 8AY PPI REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8B1 A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8B1 B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8B1 C 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8B1 D 301 DBREF 5UFI A 58 259 UNP Q96GG9 DCNL1_HUMAN 58 259 DBREF 5UFI B 58 259 UNP Q96GG9 DCNL1_HUMAN 58 259 DBREF 5UFI C 58 259 UNP Q96GG9 DCNL1_HUMAN 58 259 DBREF 5UFI D 58 259 UNP Q96GG9 DCNL1_HUMAN 58 259 SEQADV 5UFI MET A 35 UNP Q96GG9 INITIATING METHIONINE SEQADV 5UFI SER A 36 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI TYR A 37 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI TYR A 38 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI HIS A 39 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI HIS A 40 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI HIS A 41 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI HIS A 42 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI HIS A 43 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI HIS A 44 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI LEU A 45 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI GLU A 46 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI SER A 47 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI THR A 48 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI SER A 49 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI LEU A 50 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI TYR A 51 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI LYS A 52 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI LYS A 53 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI ALA A 54 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI GLY A 55 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI THR A 56 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI MET A 57 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI MET B 35 UNP Q96GG9 INITIATING METHIONINE SEQADV 5UFI SER B 36 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI TYR B 37 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI TYR B 38 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI HIS B 39 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI HIS B 40 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI HIS B 41 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI HIS B 42 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI HIS B 43 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI HIS B 44 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI LEU B 45 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI GLU B 46 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI SER B 47 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI THR B 48 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI SER B 49 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI LEU B 50 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI TYR B 51 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI LYS B 52 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI LYS B 53 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI ALA B 54 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI GLY B 55 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI THR B 56 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI MET B 57 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI MET C 35 UNP Q96GG9 INITIATING METHIONINE SEQADV 5UFI SER C 36 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI TYR C 37 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI TYR C 38 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI HIS C 39 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI HIS C 40 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI HIS C 41 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI HIS C 42 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI HIS C 43 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI HIS C 44 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI LEU C 45 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI GLU C 46 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI SER C 47 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI THR C 48 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI SER C 49 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI LEU C 50 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI TYR C 51 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI LYS C 52 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI LYS C 53 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI ALA C 54 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI GLY C 55 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI THR C 56 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI MET C 57 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI MET D 35 UNP Q96GG9 INITIATING METHIONINE SEQADV 5UFI SER D 36 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI TYR D 37 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI TYR D 38 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI HIS D 39 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI HIS D 40 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI HIS D 41 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI HIS D 42 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI HIS D 43 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI HIS D 44 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI LEU D 45 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI GLU D 46 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI SER D 47 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI THR D 48 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI SER D 49 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI LEU D 50 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI TYR D 51 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI LYS D 52 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI LYS D 53 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI ALA D 54 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI GLY D 55 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI THR D 56 UNP Q96GG9 EXPRESSION TAG SEQADV 5UFI MET D 57 UNP Q96GG9 EXPRESSION TAG SEQRES 1 A 225 MET SER TYR TYR HIS HIS HIS HIS HIS HIS LEU GLU SER SEQRES 2 A 225 THR SER LEU TYR LYS LYS ALA GLY THR MET GLY SER LEU SEQRES 3 A 225 ASP ARG LYS LYS LEU GLU GLN LEU TYR ASN ARG TYR LYS SEQRES 4 A 225 ASP PRO GLN ASP GLU ASN LYS ILE GLY ILE ASP GLY ILE SEQRES 5 A 225 GLN GLN PHE CYS ASP ASP LEU ALA LEU ASP PRO ALA SER SEQRES 6 A 225 ILE SER VAL LEU ILE ILE ALA TRP LYS PHE ARG ALA ALA SEQRES 7 A 225 THR GLN CYS GLU PHE SER LYS GLN GLU PHE MET ASP GLY SEQRES 8 A 225 MET THR GLU LEU GLY CYS ASP SER ILE GLU LYS LEU LYS SEQRES 9 A 225 ALA GLN ILE PRO LYS MET GLU GLN GLU LEU LYS GLU PRO SEQRES 10 A 225 GLY ARG PHE LYS ASP PHE TYR GLN PHE THR PHE ASN PHE SEQRES 11 A 225 ALA LYS ASN PRO GLY GLN LYS GLY LEU ASP LEU GLU MET SEQRES 12 A 225 ALA ILE ALA TYR TRP ASN LEU VAL LEU ASN GLY ARG PHE SEQRES 13 A 225 LYS PHE LEU ASP LEU TRP ASN LYS PHE LEU LEU GLU HIS SEQRES 14 A 225 HIS LYS ARG SER ILE PRO LYS ASP THR TRP ASN LEU LEU SEQRES 15 A 225 LEU ASP PHE SER THR MET ILE ALA ASP ASP MET SER ASN SEQRES 16 A 225 TYR ASP GLU GLU GLY ALA TRP PRO VAL LEU ILE ASP ASP SEQRES 17 A 225 PHE VAL GLU PHE ALA ARG PRO GLN ILE ALA GLY THR LYS SEQRES 18 A 225 SER THR THR VAL SEQRES 1 B 225 MET SER TYR TYR HIS HIS HIS HIS HIS HIS LEU GLU SER SEQRES 2 B 225 THR SER LEU TYR LYS LYS ALA GLY THR MET GLY SER LEU SEQRES 3 B 225 ASP ARG LYS LYS LEU GLU GLN LEU TYR ASN ARG TYR LYS SEQRES 4 B 225 ASP PRO GLN ASP GLU ASN LYS ILE GLY ILE ASP GLY ILE SEQRES 5 B 225 GLN GLN PHE CYS ASP ASP LEU ALA LEU ASP PRO ALA SER SEQRES 6 B 225 ILE SER VAL LEU ILE ILE ALA TRP LYS PHE ARG ALA ALA SEQRES 7 B 225 THR GLN CYS GLU PHE SER LYS GLN GLU PHE MET ASP GLY SEQRES 8 B 225 MET THR GLU LEU GLY CYS ASP SER ILE GLU LYS LEU LYS SEQRES 9 B 225 ALA GLN ILE PRO LYS MET GLU GLN GLU LEU LYS GLU PRO SEQRES 10 B 225 GLY ARG PHE LYS ASP PHE TYR GLN PHE THR PHE ASN PHE SEQRES 11 B 225 ALA LYS ASN PRO GLY GLN LYS GLY LEU ASP LEU GLU MET SEQRES 12 B 225 ALA ILE ALA TYR TRP ASN LEU VAL LEU ASN GLY ARG PHE SEQRES 13 B 225 LYS PHE LEU ASP LEU TRP ASN LYS PHE LEU LEU GLU HIS SEQRES 14 B 225 HIS LYS ARG SER ILE PRO LYS ASP THR TRP ASN LEU LEU SEQRES 15 B 225 LEU ASP PHE SER THR MET ILE ALA ASP ASP MET SER ASN SEQRES 16 B 225 TYR ASP GLU GLU GLY ALA TRP PRO VAL LEU ILE ASP ASP SEQRES 17 B 225 PHE VAL GLU PHE ALA ARG PRO GLN ILE ALA GLY THR LYS SEQRES 18 B 225 SER THR THR VAL SEQRES 1 C 225 MET SER TYR TYR HIS HIS HIS HIS HIS HIS LEU GLU SER SEQRES 2 C 225 THR SER LEU TYR LYS LYS ALA GLY THR MET GLY SER LEU SEQRES 3 C 225 ASP ARG LYS LYS LEU GLU GLN LEU TYR ASN ARG TYR LYS SEQRES 4 C 225 ASP PRO GLN ASP GLU ASN LYS ILE GLY ILE ASP GLY ILE SEQRES 5 C 225 GLN GLN PHE CYS ASP ASP LEU ALA LEU ASP PRO ALA SER SEQRES 6 C 225 ILE SER VAL LEU ILE ILE ALA TRP LYS PHE ARG ALA ALA SEQRES 7 C 225 THR GLN CYS GLU PHE SER LYS GLN GLU PHE MET ASP GLY SEQRES 8 C 225 MET THR GLU LEU GLY CYS ASP SER ILE GLU LYS LEU LYS SEQRES 9 C 225 ALA GLN ILE PRO LYS MET GLU GLN GLU LEU LYS GLU PRO SEQRES 10 C 225 GLY ARG PHE LYS ASP PHE TYR GLN PHE THR PHE ASN PHE SEQRES 11 C 225 ALA LYS ASN PRO GLY GLN LYS GLY LEU ASP LEU GLU MET SEQRES 12 C 225 ALA ILE ALA TYR TRP ASN LEU VAL LEU ASN GLY ARG PHE SEQRES 13 C 225 LYS PHE LEU ASP LEU TRP ASN LYS PHE LEU LEU GLU HIS SEQRES 14 C 225 HIS LYS ARG SER ILE PRO LYS ASP THR TRP ASN LEU LEU SEQRES 15 C 225 LEU ASP PHE SER THR MET ILE ALA ASP ASP MET SER ASN SEQRES 16 C 225 TYR ASP GLU GLU GLY ALA TRP PRO VAL LEU ILE ASP ASP SEQRES 17 C 225 PHE VAL GLU PHE ALA ARG PRO GLN ILE ALA GLY THR LYS SEQRES 18 C 225 SER THR THR VAL SEQRES 1 D 225 MET SER TYR TYR HIS HIS HIS HIS HIS HIS LEU GLU SER SEQRES 2 D 225 THR SER LEU TYR LYS LYS ALA GLY THR MET GLY SER LEU SEQRES 3 D 225 ASP ARG LYS LYS LEU GLU GLN LEU TYR ASN ARG TYR LYS SEQRES 4 D 225 ASP PRO GLN ASP GLU ASN LYS ILE GLY ILE ASP GLY ILE SEQRES 5 D 225 GLN GLN PHE CYS ASP ASP LEU ALA LEU ASP PRO ALA SER SEQRES 6 D 225 ILE SER VAL LEU ILE ILE ALA TRP LYS PHE ARG ALA ALA SEQRES 7 D 225 THR GLN CYS GLU PHE SER LYS GLN GLU PHE MET ASP GLY SEQRES 8 D 225 MET THR GLU LEU GLY CYS ASP SER ILE GLU LYS LEU LYS SEQRES 9 D 225 ALA GLN ILE PRO LYS MET GLU GLN GLU LEU LYS GLU PRO SEQRES 10 D 225 GLY ARG PHE LYS ASP PHE TYR GLN PHE THR PHE ASN PHE SEQRES 11 D 225 ALA LYS ASN PRO GLY GLN LYS GLY LEU ASP LEU GLU MET SEQRES 12 D 225 ALA ILE ALA TYR TRP ASN LEU VAL LEU ASN GLY ARG PHE SEQRES 13 D 225 LYS PHE LEU ASP LEU TRP ASN LYS PHE LEU LEU GLU HIS SEQRES 14 D 225 HIS LYS ARG SER ILE PRO LYS ASP THR TRP ASN LEU LEU SEQRES 15 D 225 LEU ASP PHE SER THR MET ILE ALA ASP ASP MET SER ASN SEQRES 16 D 225 TYR ASP GLU GLU GLY ALA TRP PRO VAL LEU ILE ASP ASP SEQRES 17 D 225 PHE VAL GLU PHE ALA ARG PRO GLN ILE ALA GLY THR LYS SEQRES 18 D 225 SER THR THR VAL HET 8B1 A 301 48 HET 8B1 B 301 41 HET 8B1 C 301 41 HET 8B1 D 301 41 HETNAM 8B1 N-[(1S)-1-CYCLOHEXYL-2-{[3-(MORPHOLIN-4-YL) HETNAM 2 8B1 PROPANOYL]AMINO}ETHYL]-N~2~-PROPANOYL-3-[6-(PROPAN-2- HETNAM 3 8B1 YL)-1,3-BENZOTHIAZOL-2-YL]-L-ALANINAMIDE FORMUL 5 8B1 4(C31 H47 N5 O4 S) FORMUL 9 HOH *40(H2 O) HELIX 1 AA1 ASP A 61 ARG A 71 1 11 HELIX 2 AA2 GLY A 82 LEU A 93 1 12 HELIX 3 AA3 SER A 99 PHE A 109 1 11 HELIX 4 AA4 LYS A 119 GLY A 130 1 12 HELIX 5 AA5 SER A 133 ALA A 139 1 7 HELIX 6 AA6 GLN A 140 LEU A 148 1 9 HELIX 7 AA7 GLY A 152 LYS A 166 1 15 HELIX 8 AA8 LEU A 175 LEU A 186 1 12 HELIX 9 AA9 PHE A 192 HIS A 203 1 12 HELIX 10 AB1 PRO A 209 ILE A 223 1 15 HELIX 11 AB2 PRO A 237 ARG A 248 1 12 HELIX 12 AB3 PRO A 249 ILE A 251 5 3 HELIX 13 AB4 ASP B 61 ASN B 70 1 10 HELIX 14 AB5 GLY B 82 LEU B 93 1 12 HELIX 15 AB6 SER B 99 PHE B 109 1 11 HELIX 16 AB7 LYS B 119 LEU B 129 1 11 HELIX 17 AB8 SER B 133 LEU B 148 1 16 HELIX 18 AB9 GLU B 150 LYS B 166 1 17 HELIX 19 AC1 ASP B 174 LEU B 186 1 13 HELIX 20 AC2 PHE B 192 GLU B 202 1 11 HELIX 21 AC3 PRO B 209 ILE B 223 1 15 HELIX 22 AC4 PRO B 237 ARG B 248 1 12 HELIX 23 AC5 PRO B 249 ILE B 251 5 3 HELIX 24 AC6 ASP C 61 ARG C 71 1 11 HELIX 25 AC7 GLY C 82 LEU C 93 1 12 HELIX 26 AC8 SER C 99 PHE C 109 1 11 HELIX 27 AC9 SER C 118 GLY C 130 1 13 HELIX 28 AD1 SER C 133 LEU C 148 1 16 HELIX 29 AD2 GLY C 152 LYS C 166 1 15 HELIX 30 AD3 LEU C 175 LEU C 186 1 12 HELIX 31 AD4 PHE C 192 HIS C 204 1 13 HELIX 32 AD5 PRO C 209 ILE C 223 1 15 HELIX 33 AD6 PRO C 237 ARG C 248 1 12 HELIX 34 AD7 PRO C 249 ILE C 251 5 3 HELIX 35 AD8 ASP D 61 LYS D 73 1 13 HELIX 36 AD9 GLY D 82 ALA D 94 1 13 HELIX 37 AE1 SER D 99 PHE D 109 1 11 HELIX 38 AE2 LYS D 119 GLY D 130 1 12 HELIX 39 AE3 SER D 133 ALA D 139 1 7 HELIX 40 AE4 GLN D 140 LEU D 148 1 9 HELIX 41 AE5 GLY D 152 LYS D 166 1 15 HELIX 42 AE6 LEU D 175 LEU D 186 1 12 HELIX 43 AE7 PHE D 192 HIS D 204 1 13 HELIX 44 AE8 PRO D 209 ILE D 223 1 15 HELIX 45 AE9 PRO D 237 ARG D 248 1 12 HELIX 46 AF1 PRO D 249 ILE D 251 5 3 SHEET 1 AA1 3 LYS A 73 ASP A 74 0 SHEET 2 AA1 3 ASP A 77 ILE A 81 -1 O LYS A 80 N ASP A 74 SHEET 3 AA1 3 PHE A 117 SER A 118 -1 O PHE A 117 N ILE A 81 SHEET 1 AA2 2 LEU A 173 ASP A 174 0 SHEET 2 AA2 2 SER A 207 ILE A 208 -1 O ILE A 208 N LEU A 173 SHEET 1 AA3 2 LYS B 80 ILE B 81 0 SHEET 2 AA3 2 PHE B 117 SER B 118 -1 O PHE B 117 N ILE B 81 SHEET 1 AA4 2 LEU C 173 ASP C 174 0 SHEET 2 AA4 2 SER C 207 ILE C 208 -1 O ILE C 208 N LEU C 173 SHEET 1 AA5 2 LYS D 80 ILE D 81 0 SHEET 2 AA5 2 PHE D 117 SER D 118 -1 O PHE D 117 N ILE D 81 SHEET 1 AA6 2 LEU D 173 ASP D 174 0 SHEET 2 AA6 2 SER D 207 ILE D 208 -1 O ILE D 208 N LEU D 173 SITE 1 AC1 17 PHE A 89 PRO A 97 SER A 99 VAL A 102 SITE 2 AC1 17 ALA A 106 GLN A 114 CYS A 115 GLU A 116 SITE 3 AC1 17 PHE A 117 PHE A 164 MET A 177 TYR A 181 SITE 4 AC1 17 LEU A 184 ILE C 83 GLN C 87 PRO C 97 SITE 5 AC1 17 8B1 C 301 SITE 1 AC2 14 PHE B 89 PRO B 97 SER B 99 VAL B 102 SITE 2 AC2 14 GLN B 114 CYS B 115 GLU B 116 PHE B 117 SITE 3 AC2 14 PHE B 164 MET B 177 ALA B 180 TYR B 181 SITE 4 AC2 14 GLN D 87 8B1 D 301 SITE 1 AC3 10 8B1 A 301 PHE C 89 PRO C 97 GLN C 114 SITE 2 AC3 10 CYS C 115 GLU C 116 PHE C 117 PHE C 164 SITE 3 AC3 10 MET C 177 TYR C 181 SITE 1 AC4 14 ILE B 86 PRO B 97 8B1 B 301 ILE D 86 SITE 2 AC4 14 PHE D 89 PRO D 97 VAL D 102 ALA D 106 SITE 3 AC4 14 GLN D 114 CYS D 115 GLU D 116 PHE D 164 SITE 4 AC4 14 MET D 177 TYR D 181 CRYST1 62.142 101.647 173.521 90.00 90.00 90.00 P 21 21 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016092 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009838 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005763 0.00000